CLINICAL_TRIALS
trial_result
· 2007-09-11
Clinical Trial Update: Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 [Phase 2]
Summary
Phase 2 clinical trial update assessing the glucose-lowering effect, safety and tolerability of CS-917 in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED